Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Diagnostic Vitrectomy for Infectious Uveitis
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD
Overcoming Real-World Barriers to TED Treatment
Applying CAS, EUGOGO, VISA: A Micro Case
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Why Staging TED Correctly Matters Even When CAS Is Low
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Designing Efficient Clinic Workflows for TED Therapy Access
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.